Atorvastatin should not be given to patients with acute liver disease or unexplained persistent raised serum-aminotransferase concentrations or to those with porphyria. It should be avoided during pregnancy since there is a possibility that it could interfere with fetal sterol synthesis. It should be used with caution in patients with severe renal impairment.